Teva UK court decision threatens 'at-risk' generic launches
This article was originally published in SRA
Executive Summary
A decision on 9 July by the UK High Court to grant an injunction against a potential 'at-risk' generic launch has dealt a serious blow to generic companies planning such launches in the UK.